Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-07-22
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514444, 549 60, 549214, 549268, A61K 31335
Patent
active
056504306
ABSTRACT:
Radicicol derivatives in which one or both hydroxy groups are acylated have valuable anti-tumor activity or may be used as chemical intermediates.
REFERENCES:
patent: 3428526 (1969-02-01), Sigg et al.
patent: 4166764 (1979-09-01), Calton et al.
patent: 4228079 (1980-10-01), Calton et al.
Mirrington et al `The Constitution of Radicicol` Tetrahedron Letters, No. 7, 1964, pp. 365-370.
Chem Abst., vol. 77, No. 25 (1972) No. 160508q.
Chem Abst., vol. 61 (1964) 14653 (McCapra et al).
Merck Index, Tenth Ed. 1983 pp. 894-895 Monograph No. 6107 "Monorden".
Chem Abst. vol. 60, (1964), 10623, (Mirrington).
Burger, A. A Guide to the Chemical Basis & Drug Design p. 15 1984.
Cutler et al, "Monorden from a Novel Source, Neocosmospora tenuicristata: Stereochemistry and Plant Growth Regulatory Properties", Agri. Biol. Chem. 51 (12) pp. 3331-3337, 1987.
Iino Kimio
Kagasaki Takeshi
Kobayashi Tomowo
Shimada Yoko
Sugimura Yukio
Owens Amelia
Sankyo Company Limited
LandOfFree
Radicicol derivatives, their preparation and their anti-tumor ac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radicicol derivatives, their preparation and their anti-tumor ac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radicicol derivatives, their preparation and their anti-tumor ac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560284